Idexx Laboratories Inc vs. Lantheus Holdings, Inc
Idexx Laboratories Inc (IDXX) comes out ahead, leading on 5 of 9 compared factors.
Size & Scale
| IDXX | LNTH | |
|---|---|---|
| Market Cap | $39.90 billion | $6.56 billion |
| Revenue (TTM) | $4.55 billion | $1.56 billion |
| Net Income (TTM) | $1.14 billion | $275.31 million |
IDXX leads on 3 of 3 size & scale factors.
Valuation
| IDXX | LNTH | |
|---|---|---|
| P/E Ratio | 35.96 | 24.27 |
| Price / Book | 24.74 | 5.00 |
| Price / Sales | 8.76 | 4.21 |
LNTH leads on 3 of 3 valuation factors.
Profitability
| IDXX | LNTH | |
|---|---|---|
| Net Margin | 25.03% | 17.69% |
| Return on Equity | 70.67% | 20.99% |
IDXX leads on 2 of 2 profitability factors.
Risk & Sentiment
| IDXX | LNTH | |
|---|---|---|
| Short Interest | 1.79% | 0.72% |
LNTH leads on 1 of 1 risk & sentiment factors.
Dig deeper: IDXX overview, IDXX financials, LNTH overview, LNTH financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.